US Stock MarketDetailed Quotes
AEMD Aethlon Medical
- 0.4032
- -0.0011-0.27%
Close Nov 25 16:00 ET
- 0.4145
- +0.0113+2.80%
Post 19:15 ET
5.63MMarket Cap-144P/E (TTM)
0.4147High0.3919Low130.71KVolume0.3940Open0.4043Pre Close52.31KTurnover0.94%Turnover RatioLossP/E (Static)13.96MShares2.349952wk High0.94P/B5.59MFloat Cap0.237552wk Low--Dividend TTM13.86MShs Float67499.9865Historical High--Div YieldTTM5.64%Amplitude0.2375Historical Low0.4000Avg Price1Lot Size
About Aethlon Medical Company
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
Company Profile
SymbolAEMD
Company NameAethlon Medical
Listing DateJul 13, 2015
Founded1991
CEOMr. James B. Frakes
MarketNASDAQ
Employees14
Fiscal Year Ends03-31
Address11555 Sorrento Valley Road,Suite 203
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-619-941-0360
Company Executives
- Name
- Position
- Salary
- James B. Frakes
- Director, Chief Financial Officer, Chief Executive Officer and Principal Accounting Officer
- 416.45K
- Dr. Steven P. Larosa, M.D.
- Chief Medical Officer
- 430.00K
- Edward G. Broenniman
- Chairman of the Board
- 147.50K
- Dr. Chetan S. Shah, M.D.
- Independent Director
- 113.75K
- Angela Rossetti
- Independent Director
- 113.00K
- Nicolas Gikakis
- Independent Director
- 112.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data